Literature DB >> 9458245

Adeno-associated virus gene transfer to mouse retina.

R R Ali1, M B Reichel, M De Alwis, N Kanuga, C Kinnon, R J Levinsky, D M Hunt, S S Bhattacharya, A J Thrasher.   

Abstract

Ocular gene transfer may provide a means for arresting the retinal degeneration characteristic of many inherited causes of blindness, including retinitis pigmentosa (RP). Previously, we have shown in immunodeficient animals that recombinant adeno-associated virus (rAAV) mediates transduction of photoreceptors as well as the retinal pigment epithelium (RPE) following subretinal injection. In this study we extend these observations and show that highly purified recombinant AAV vectors encoding the reporter gene LacZ transduce photoreceptors in an immunocompetent mouse strain following subretinal injection and efficiently transduce ganglion cells after intravitreal injection. Levels of transduction increase over time. Sublethal gamma-irradiation is shown to facilitate this process.

Entities:  

Mesh:

Year:  1998        PMID: 9458245     DOI: 10.1089/hum.1998.9.1-81

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  31 in total

1.  TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo.

Authors:  Li Cheng; Przemyslaw Sapieha; Pavla Kittlerova; William W Hauswirth; Adriana Di Polo
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

2.  Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy.

Authors:  M M LaVail; D Yasumura; M T Matthes; K A Drenser; J G Flannery; A S Lewin; W W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  AAV gene transfer to the retina does not protect retrovirally transduced hepatocytes from the immune response.

Authors:  Marta Bellodi-Privato; Guylène Le Meur; Dominique Aubert; Alexandra Mendes-Madera; Virginie Pichard; Fabienne Rolling; Nicolas Ferry
Journal:  J Mol Med (Berl)       Date:  2004-03-24       Impact factor: 4.599

Review 4.  Channelrhodopsins provide a breakthrough insight into strategies for curing blindness.

Authors:  Hiroshi Tomita; Eriko Sugano; Hitomi Isago; Makoto Tamai
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

5.  Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.

Authors:  J H McIntosh; M Cochrane; S Cobbold; H Waldmann; S A Nathwani; A M Davidoff; A C Nathwani
Journal:  Gene Ther       Date:  2011-06-30       Impact factor: 5.250

6.  Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse.

Authors:  S Arnhold; Y Absenger; H Klein; K Addicks; U Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-04       Impact factor: 3.117

7.  Retina transduction by rAAV2 after intravitreal injection: comparison between mouse and rat.

Authors:  Mariana S Dias; Victor G Araujo; Taliane Vasconcelos; Qiuhong Li; William W Hauswirth; Rafael Linden; Hilda Petrs-Silva
Journal:  Gene Ther       Date:  2019-09-27       Impact factor: 5.250

8.  Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity.

Authors:  I Chowers; E Banin; Y Hemo; R Porat; H Falk; E Keshet; J Pe'er; A Panet
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

9.  P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice.

Authors:  May Nour; Alexander B Quiambao; Ward M Peterson; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

10.  Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist.

Authors:  Ming-Ling Tsai; Chi-Ting Horng; Show-Li Chen; Xiao Xiao; Chih-Hung Wang; Yeou-Ping Tsao
Journal:  Mol Vis       Date:  2009-08-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.